Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Clinical Pharmacology and Therapeutics
|
February 6, 2021
Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration
Olivier Le Tilly, Nicolas Azzopardi, Claire Bonneau, et al.
Neuro-Oncology
|
July 22, 2022
Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis
Florence Oberkampf, Maya Gutierrez, Olfa Trabelsi Grati, et al.
Journal of Translational Medicine
|
July 27, 2010
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
Chrystelle Brignone, Maya Gutierrez, Fawzia Mefti, et al.
Arthritis and Rheumatism
|
November 6, 2004
Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection
Laurent Vallat, Yves Benhamou, Maya Gutierrez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 11, 2018
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
Claire Bonneau, Gilles Paintaud, Olivier Trédan, et al.
BMC Cancer
|
March 11, 2014
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study
Thomas Bachelot, Jose A Garcia-Saenz, Sunil Verma, et al.
The Lancet. Oncology
|
November 6, 2012
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot, Gilles Romieu, Mario Campone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy
Romuald Le Scodan, Denise Stevens, Etienne Brain, et al.
BMC Health Services Research
|
November 2, 2013
Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study
Sandrine Baffert, Paul Cottu, Youlia M Kirova, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Clinical Pharmacology and Therapeutics
|
February 6, 2021
Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration
Olivier Le Tilly, Nicolas Azzopardi, Claire Bonneau, et al.
Neuro-Oncology
|
July 22, 2022
Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis
Florence Oberkampf, Maya Gutierrez, Olfa Trabelsi Grati, et al.
Journal of Translational Medicine
|
July 27, 2010
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
Chrystelle Brignone, Maya Gutierrez, Fawzia Mefti, et al.
Arthritis and Rheumatism
|
November 6, 2004
Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection
Laurent Vallat, Yves Benhamou, Maya Gutierrez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 11, 2018
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
Claire Bonneau, Gilles Paintaud, Olivier Trédan, et al.
BMC Cancer
|
March 11, 2014
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study
Thomas Bachelot, Jose A Garcia-Saenz, Sunil Verma, et al.
The Lancet. Oncology
|
November 6, 2012
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot, Gilles Romieu, Mario Campone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy
Romuald Le Scodan, Denise Stevens, Etienne Brain, et al.
BMC Health Services Research
|
November 2, 2013
Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study
Sandrine Baffert, Paul Cottu, Youlia M Kirova, et al.
Page
of 2